RHOBTB1抗体—艾普蒂

+ +

•  

   

     Gel: 6%SDS-PAGE, Lysate: 40 μg, Lane: A431 cells, Primary antibody: P08699(RHOBTB1 Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 30 seconds    

  
  

**Background of RHOBTB1 Antibody**

RHOBTB1 (Rho-related BTB domain-containing protein 1) is a member of the Rho GTPase family, which regulates diverse cellular processes, including cytoskeletal dynamics, vesicular trafficking, and cell cycle progression. Unlike canonical Rho GTPases, RHOBTB1 contains two BTB (Broad-Complex, Tramtrack, and Bric-à-brac) domains, enabling interactions with Cullin 3 (CUL3) to form E3 ubiquitin ligase complexes. This links RHOBTB1 to the ubiquitin-proteasome system, where it facilitates substrate recognition and protein degradation.

RHOBTB1 is implicated in tumor suppression, with reduced expression observed in cancers like breast and colorectal carcinoma, where it correlates with poor prognosis. It regulates cell cycle arrest, apoptosis, and migration by targeting oncoproteins for degradation. Additionally, RHOBTB1 plays roles in neuronal development and autophagy, with dysregulation linked to neurodegenerative disorders.

Antibodies against RHOBTB1 are essential tools for studying its expression, localization, and interactions. They are commonly used in techniques such as Western blotting, immunohistochemistry, and immunofluorescence. Validated antibodies help elucidate RHOBTB1’s regulatory mechanisms in disease contexts, aiding research into therapeutic strategies targeting its pathways. Specificity is confirmed via knockout controls, ensuring reliable detection in both normal and pathological tissues.